RARE DISEASE COMPANY COALITION

• RARE DISEASE COMPANY COALITION $550,000 In-house, the client's own filings · 8 filings
• FEROX STRATEGIES $300,000 Outside firm · 7 filings
• LMH STRATEGIC SOLUTIONS $40,000 Outside firm · 2 filings

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

• H.R. 1262
  Mikaela Naylon Give Kids a Chance Act
  5 filings
• H.R. 1414
  Cameron’s Law
  5 filings
• H.R. 1
  One Big Beautiful Bill Act
  3 filings
• H.R. 946
  ORPHAN Cures Act
  3 filings
• H.R. 1532
  Scientific EXPERT Act of 2025
  2 filings
• H.R. 4758
  Accelerating Kids’ Access to Care Act
  1 filing
• H.R. 7384
  Creating Hope Reauthorization Act of 2024
  1 filing
• H.R. 10359
  Priority for Pediatric Cures Act
  1 filing
• H.R. 1762
  Forest Service Accountability Act
  1 filing
• H.R. 7148
  Consolidated Appropriations Act, 2026
  1 filing
• S. 822
  Scientific EXPERT Act of 2025
  1 filing

• 2026 $410,000 6 filings
• 2025 $480,000 11 filings

• Health Issues 10
• Pharmacy 9
• Trade (domestic/foreign) 9
• Taxation/Internal Revenue Code 8
• Science/Technology 4
• Budget/Appropriations 2
• Medicare/Medicaid 1

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

• HOUSE OF REPRESENTATIVES 14
• SENATE 14
• Commerce, Dept of (DOC) 5
• Health & Human Services, Dept of (HHS) 5
• Executive Office of the President (EOP) 4
• Office of Management & Budget (OMB) 2
• Centers For Medicare and Medicaid Services (CMS) 1
• Food & Drug Administration (FDA) 1
• U.S. Trade Representative (USTR) 1
• White House Office 1